Vimarsana
Biggest News Aggregation in the World

Johnp Stapp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johnp Stapp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johnp Stapp Today - Breaking & Trending Today

A trail commemorating New Mexico's history of looking to the stars - Vimarsana News

A trail commemorating New Mexico's history of looking to the stars

New Mexico’s history is long and colorful stretching from deep into prehistory to Indigieous stories to the Spanish colonization of the American Southwest to being a major point in America’s part in space exploration and tourism. One of the ways recently established to celebrate the latter was the New Mexico Space Trail which commemorates 52 […]

Coronavirus: Confusion over efficacy of Chinese vaccines | Science| In-depth reporting on science and technology | DW - Vimarsana News

Coronavirus: Confusion over efficacy of Chinese vaccines | Science| In-depth reporting on science and technology | DW

Indonesia begins coronavirus vaccine rollout CanSino's fourth Chinese vaccine is a vector vaccine based on an adenovirus type 5, making it comparable in mode of action to AstraZeneca's vaccine. It is expected to achieve an efficacy of 65%. In principle, the efficacy values improve even further to over 80% when only severe courses  of disease are taken into account, namely those that also require hospitalization. Combination of vaccines not unusual The idea of combining vaccines to increase efficacy is not fundamentally new. Scientists are currently discussing similar approaches for AstraZe...

Source: dw.com
AstraZeneca: What′s the deal with thrombosis? | Science| In-depth reporting on science and technology | DW - Vimarsana News

AstraZeneca: What′s the deal with thrombosis? | Science| In-depth reporting on science and technology | DW

German EU lawmaker Katarina Barley on vaccine dilemmas However, this type of thrombosis is considered rather rare, looking at its incidence: It is estimated that two to five people per 1 million experience CVST over the course of a year. However, recent studies indicate a higher number of people affected. As many as 15.7 cases per million people per year have been reported in an Australian study, says Paul Hunter, professor of medicine at the University of East Anglia. That would mean the current incidence is underestimated by four to eight times, according to Hunter. Does thrombosis always ...

Source: dw.com
Opinion: Do not write off the AstraZeneca vaccine | Science| In-depth reporting on science and technology | DW - Vimarsana News

Opinion: Do not write off the AstraZeneca vaccine | Science| In-depth reporting on science and technology | DW

The dangers of thrombosis High risk of thrombosis in everyday life All of this is no reason to panic: We deliberately take on much higher thrombosis risks elsewhere than they might now — perhaps — come by the way of vaccination. In a well-known and scientifically proved example, for every million women who take the birth control pill, about 1,100 will get thrombosis. In addition, various circumstances or behaviors  have been shown to double our risk of thrombosis. These include: obesity, travel (especially long-distance flights, car, bus or train rides) and  smoking.  All of these fa...

Source: dw.com
COVID: Sanofi starts human trials of 2nd vaccine candidate | News | DW - Vimarsana News

COVID: Sanofi starts human trials of 2nd vaccine candidate | News | DW

COVID-19 vaccination: Voices from around the world Participants will receive either a single dose of the vaccine or two doses 21 days apart. Three dose levels will be examined, the companies said. When could the vaccine get approval? In December 2020, Sanofi had said it was eyeing "earliest potential approval" of its mRNA vaccine in the second half of 2021, following positive preclinical data. Researchers and their self-experiments An oral vaccination against coronavirus Courage, curiosity or complete hubris? It's probably a mixture of all these things that causes many scientists to test thei...

Source: dw.com